与阿片类药物相关的呼吸系统抑郁症:叙述审查
Mellar P Davis1, Sandra DiScala2, Amy Davis3
1Geisinger Medical Center, Danville, PA, USA. mdavis2@geisinger.edu.
Current treatment options in oncology
|October 21, 2024
概括
在阿片类药物中,芬太尼对呼吸系统抑郁和大脑循环减少的风险最高. 在阿片类药物流行期间,建议在疼痛管理中使用比较安全的替代品,如布普伦诺芬,吗啡或水墨.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 疼痛管理 疼痛管理
背景情况:
- 阿片类药物通常用于缓解疼痛,但具有重大风险.
- 呼吸抑制和大脑循环减少是所有阿片类药物的已知的不良影响.
- 芬太尼对这些不良反应具有更高的风险概况,特别是当与海洛因等非法阿片类药物相结合时.
研究的目的:
- 评估常见处方阿片类药物的比较风险.
- 强调阿片类药物安全在临床实践中的重要性.
- 为了指导临床医生在持续的阿片类药物流行中选择更安全的阿片类止痛药.
主要方法:
- 这是一个基于现有知识和临床共识的意见稿.
- 它涉及对各种阿片类药物的已知药理和毒理资料的审查.
- 分析的重点是呼吸系统抑郁的比较风险,大脑循环效应和滥用潜力.
主要成果:
- 芬太尼具有最大的呼吸抑制和大脑循环减少的风险.
- 非法阿片类药物,如二甲胺 (海洛因),加剧这些风险,当与芬太尼结合.
- 虽然在止痛方面有效,但阿片类药物的相对安全性需要在处方时仔细考虑.
结论:
- 由于其重大风险,芬太尼不应被视为一线强效阿片类药物.
- 布普伦诺芬,吗啡或摩是首选的阿片类药物选择,其次是氧化.
- 在国际阿片类药物危机的背景下,临床医生必须优先选择安全和明智的阿片类止痛药.
相关概念视频
Depressants
101
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
101
Opioid Analgesics: Morphine and Other Natural Cogeners
187
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
187
Acute Respiratory Failure-IV
129
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
129
Opioid Analgesics: Synthetic and Semisynthetic Opioids
234
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
234
CNS Depressants: Barbiturates and Benzodiazepines
228
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
228
Acute Respiratory Failure-II
174
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
174


